AGC Biologics Capabilities Update September 2026: mRNA

A single mRNA product passes through several distinct unit operations, often under tight timelines, and the quality set at the plasmid stage carries into everything built on it.

Dominic Leier, team leader in process development for DNA and RNA projects at HEC Biologics in Heidelberg, walks through an end-to-end platform from pDNA through IVT, LNP assembly, and aseptic filling for smaller batches. He addresses capping approaches, mixing technologies, in-house analytics, and how production scales differ between R&D and GMP, and he also covers the Yokohama site's scale-up role.

Watch the webinar to hear how a customizable platform process is structured across the full chain.